Health advice for international travelers living with Parkinson disease

Document Type : Mini Review

Authors

1 School of Medicine, University of Galway, Galway, Ireland

2 School of Medicine and Medical Science, University College Dublin, Dublin, Ireland

3 Department of Neurology, University Hospital Galway, Galway, Ireland

10.30491/ijtmgh.2022.161914

Abstract

Parkinson disease is a progressive neurodegenerative disorder affecting the dopaminergic neurons of the basal ganglia, affecting approximately 1% of individuals over the age of 65. The travel health challenges of patients with Parkinson disease have not been adequately addressed in the medical literature. This perspective article discusses the barriers to healthy travel in this vulnerable population and considers mitigating measures. It focuses on difficulties with mobility, cognitive impairment, chronic medications, and medical devices.

Keywords

International Journal of Travel Medicine and Global Health
Volume 10, Issue 4 - Serial Number 39
December 2022
Pages 155-158

Files

History

  • Receive Date: 10 October 2022
  • Revise Date: 07 November 2022
  • Accept Date: 11 November 2022
  • First Publish Date: 30 November 2022

Share

How to cite

Statistics